Layton, Targacept deal

Targacept acquired Layton's Inversine mecamylamine nicotinic acetylcholine

Read the full 79 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE